Skip to main content
Caplight Logo









Histofy

Histofy

Private
CoventryHealthcare & Life Scienceshttps://www.histofy.ai/

Last Round

Strategic

May 6, 2025

Total Funding Raised

$600,000

Company Overview

Histofy is a healthtech company that develops transparent AI solutions for computational pathology, with a focus on tissue-based diagnostics and prognostics.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Clinical Trials, Drug Discovery, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

computational pathologypathology AIdigital pathologyAI diagnosticsmedical imaging AImitosis quantificationcancer gradingtissue image analysiswhole-slide imagingexplainable AIdrug discovery toolsclinical trial supporttoxicologic pathologycomputer visionagentic AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Histofy Comparables

Compare Histofy with similar companies based on industry and business-model similarity.

Histofy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qritive
87%
Aiosyn
84%
MindPeak
83%

Histofy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 6, 2025
SeedJul 10, 2024
GrantMar 10, 2023

Key People

Founding team and executive leadership

David Snead

Co-founder and Chief Medical Officer

Founding Team

Simon Graham

Co-Founder and Chief Technology Officer

Founding Team

Nasir Rajpoot

CEO & CSO

Executive Team

Histofy Investors

Notable investors and investment history

Histofy investors
InvestorRounds
LumiaresSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 624% MoM, from 135 to 977.

  • Jun 2, 2025

    Monthly visitors grew 105% MoM, reaching 940.

Histofy Filings

Explore SEC and related filing metadata, where available.

Histofy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Histofy's valuation, stock price, and market status.

Is Histofy a public or private company?

Histofy is a private company.

What is the current stock price of Histofy?

Histofy is a private company with no public stock price. No recent secondary market data is available.

How much is Histofy worth (valuation)?

Valuation information for Histofy is not publicly available.

Can I buy Histofy stock?

Histofy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Histofy's last funding round?

Histofy's most recent funding round was Strategic on May 6, 2025.

Who are the main investors in Histofy?

Key investors in Histofy include Lumiares.

Will Histofy IPO soon?

No public IPO plans have been announced for Histofy.

How can I track Histofy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Histofy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCoventry
Employee Range9
Year Founded2021
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?